David V Glidden

Biographic Data

ID	6259529
NAME	David V Glidden
GIVEN NAMES	David V
FAMILY NAME	Glidden
SIGNATURE	GLIDDEN D V
AFFILIATIONS	University of California, San Francisco
ORCID	0000-0001-5888-1419
VERIFIED	Yes
TOTAL WORKS	18
TOTAL CITATIONS	1
AUTHOR COUNT	18
EDITOR COUNT	0
FIRST PUBLICATION YEAR	1991
LATEST PUBLICATION YEAR	2025
H-INDEX	1

Post-Omicron Sars-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurvey
Open AccessSmit Chitre, M Bailor Barrie et al.ARTICLEPLOS Global Public Health2025
Based on a serosurvey conducted in March 2021, Barrie and colleagues published the first nationally representative SARS-CoV-2 serosurvey in Africa, estimating a SARS-CoV-2 seroprevalence of 2.6% in Sierra Leone, 43 times higher than the reported number of cases at that time. Over the following two years, increasingly transmissible variants—specifically Delta and Omicron—proliferated across the globe, and their impact in Africa is poorly understoo…
The role of seasonal malaria chemoprevention in the effect of azithromycin on child mortality: A secondary analysis of the CHAT cluster randomized clinical trial
Open AccessElisabeth Gebreegziabher, Mamadou Ouattara et al.ARTICLEPLOS Global Public Health2025
The objective of this study was to examine whether the effect of mass Azithromycin (AZ) distribution on all-cause mortality among children under 5 varies with seasonal malaria chemoprevention (SMC) administration season or coverage. This was a secondary analysis of the Community Health with Azithromycin Trial (CHAT), a cluster-randomized, placebo-controlled trial of twice-yearly AZ treatment in 341 communities in the Nouna District, Burkina Faso.…
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group
Open AccessRobin Schaefer, L J Donaldson et al.ARTICLEPLOS Global Public Health2024
This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV045445]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The Forum for Collaborative Research, as an organization, also receives grants from the pharmaceutical industry but these are unrestricted and not s…
Association of body mass index with progression from binge-eating behavior into binge-eating disorder among adolescents in the United States: A prospective analysis of pooled data
Open AccessAbubakr A A Al-shoaibi, Jason M Lavender et al.ARTICLEAppetite2024Cited by: 1References: 45
The association between body mass index (BMI) and binge-eating disorder (BED) is well-established. However, data on the extent to which BMI is associated with progression from binge-eating behavior into BED among adolescents are limited, which was the aim of this investigation. Participants were 9964 U.S. adolescents from the Adolescent Brain Cognitive Development (ABCD) Study, aged 9-13 at the time of study enrollment. A computerized parent-repo…
A Feasibility Study of a Remotely-Delivered Mindfulness-Based Training for Adolescents During the Covid-19 Pandemic
Open AccessOlga Tymofiyeva, Melody Y Hu et al.ARTICLEFrontiers in Psychiatry2022
Our results support the feasibility of TARA delivered over Zoom. While our primary outcome did not provide support for the improvement of the emotional wellbeing with TARA compared to a passive control group, our exploratory analysis in the intervention group indicated an improved functioning over the weeks of TARA training. The important general positive impact of this study lies in the possibility of offering a neuroscience-based mindfulness in…
HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis
J Carlo Hojilla, Megha Mehrotra et al.ARTICLEAIDS Care2018
HIV pre-exposure prophyalxis (PrEP) might lead individuals to view serodisclosure as unnecessary. We examined the prevalence of non-disclosure and lack of knowledge of partner status in a global cohort of men who have sex with men (MSM) and transgender women (TW) enrolled in the iPrEx Open Label Extension (OLE). We calculated prevalence ratios by fitting a logistic model and estimating predicted probabilities using marginal standardization. Preva…
Perceived Social Norms About Oral PrEP Use: Differences Between African–American, Latino and White Gay, Bisexual and Other Men Who Have Sex with Men in Texas
Open AccessPhillip Schnarrs, Danielle Gordon et al.ARTICLEAIDS and Behavior2018
The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men
Open AccessMegha Mehrotra, Megha L Mehrotra et al.ARTICLEAIDS and Behavior2018
Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China
Open AccessKathrine Meyers, Yumeng Wu et al.ARTICLEAIDS and Behavior2017
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study
Open AccessMegha Mehrotra, Megha L Mehrotra et al.ARTICLEAIDS and Behavior2016
HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
Open AccessMadeline B Deutsch, David V Glidden et al.ARTICLEThe Lancet HIV2015
Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
Open Accessfor the iPrEx Study Team, Patricia Defechereux et al.ARTICLEAIDS and Behavior2015
We conducted a longitudinal and cross-sectional analysis of depressive symptomology in iPrEx, a randomized, placebo-controlled trial of daily, oral FTC/TDF HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men. Depression-related adverse events (AEs) were the most frequently reported severe or life-threatening AEs and were not associated with being randomized to the FTC/TDF arm (152 vs. 144 respectively OR 0.66 95…
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study
Open AccessRobert M Grant, Peter L Anderson et al.ARTICLEThe Lancet Infectious Diseases2014
Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models
Open AccessEric Vittinghoff, David V Glidden et al.BOOKRegression Methods in Biostatistics2012
Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men
Peter L Anderson, David V Glidden et al.ARTICLEScience Translational Medicine2012
PrEP drug concentrations associated with ≥90% reduction in HIV acquisition in men who have sex with men are achieved with daily dosing.
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M Grant, Javier R Lama et al.ARTICLENew England Journal of Medicine2010
BACKGROUND: Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition. METHODS: We randomly assigned 2499 HIV-seronegative men or transgender women who have sex with men to receive a combination of two oral antiretroviral drugs, emtricitabine and tenofovir disoproxil fumarate (FTC-TDF), or placebo once daily. All subjects received HIV testing, risk-reduction counse…
Borderline disorders
David Glidden, David V GliddenARTICLEPhilosophy and Geography2002
Survival trends of people with Aids in Washington State
William E Lafferty, D Glidden et al.ARTICLEAmerican Journal of Public Health1991References: 7
Survival rates of 609 cases of acquired immunodeficiency syndrome (AIDS) in Washington State diagnosed between 1982 and 1987 according to pre-1987 AIDS surveillance definition were analyzed. People with a primary diagnosis of Kaposi's sarcoma survived longer than those with Pneumocystis carinii pneumonia. Both groups survived longer than those with other diagnoses. Median survival increased from 11.3, to 12.5, to 20.8 months for cases diagnosed i…